Glycate Tablets and Insulin glargine and lixisenatide
Determining the interaction of Glycate Tablets and Insulin glargine and lixisenatide and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glycopyrrolate
Brand name: Cuvposa, GLYRX-PF, Robinul, Robinul Forte, Lonhala Magnair Starter Kit, Seebri Neohaler
Synonyms: Glycopyrrolate, Glycopyrrolate (Oral Inhalation)
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin Glargine and Lixisenatide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glycate Tablets-Insulin glargine and lixisenatide Subcutaneous
- Glycate Tablets-Insulin glargine, recombinant Subcutaneous
- Glycate Tablets-Insulin glulisine
- Glycate Tablets-Insulin Glulisine (Cartridges and Pens)
- Glycate Tablets-Insulin Glulisine (Vials)
- Glycate Tablets-Insulin glulisine Subcutaneous
- Insulin glargine and lixisenatide-Glycerin and Lidocaine
- Insulin glargine and lixisenatide-Glycerin Enema
- Insulin glargine and lixisenatide-Glycerin rectal
- Insulin glargine and lixisenatide-Glycerin Suppositories
- Insulin glargine and lixisenatide-Glycerol phenylbutyrate
- Insulin glargine and lixisenatide-GlycoLax